Universal linker compositions for the release or transfer of chemical agents from a polynucleotide
View Patent ↗A universal linker structure is provided, in which a functional group and activating leaving group are placed on a tether, allowing the placement of an electrophile at the end of any nucleic acid sequence. The electrophile on the tether can react with a second nucleic acid carrying a nucleophile when the two nucleic acids are hybridized near one another, resulting in release of the leaving group, and creation of a functional change. The linker can be designed to destabilize the ligation product without slowing the rate of reaction. This lowers product inhibition, and the target DNA or RNA can become a catalyst for isothermally generating multiple signals for detection. This enhanced signal is demonstrated in solution experiments and in solid supported assays. The universal linkers of the present invention are simple and inexpensive to prepare, and can be appended to any polynucleotide in automated steps on a standard DNA synthesizer.
1. A modified polynucleotide having the structure:
wherein T is a tether selected from the group consisting of:
where n is from 2 to 20; and n 1 and n 2 are independently selected to be from 1 to 20; wherein n 1 +n 2 are usually not more than about 20; and y is from 1 to 7;
and wherein T is optionally substituted with an alkyl, aryl, alkenyl, aralkyl, aralkenyl, cycloalkyl, cycloalkylalkyl or cycloalkylalkenyl group;
R 3 is selected from an alkyl, usually branched or linear lower alkyl; hydroxy, alkoxy, aryloxy, haloalkoxy, cyano, nitro, mercapto, alkylthio, —S(O) p R 6 (where p is 0 to 2), —S(O) p N(R 6 ) 2 (where p is 0 to 2); —OR 6 , —C(O)OR 6 , —C(O)N(R 6 ) 2 , —N(R 6 ) 2 , —N(R 6 )C(O)OR 7 , —N(R 8 )C(O)R 8 , and —R 8 —N═N—O—R 7 ; where each R 6 , R 7 or R 8 is independently selected from the group consisting of hydrogen, alkyl, alkenyl, haloalkyl, haloalkenyl, aryl, aralkyl, aralkenyl, cycloalkyl, cycloalkylalkyl and cycloalkylalkenyl;
L is an activated leaving group selected from sulfonyl, carbonyl esters, para nitrophenyl esters, nitrophenyl esters, trifluoroacetyl esters, nosylate, brosylate, tosylate, perchlorate, triflate, and mesylate;
Z is a fluorophore or quencher;
A is a nucleotide of at least 6 bases in length and not more than about 100 bases in length; and
R is OR 1 or O − ; wherein R 1 is a linear or branched lower alkyl.
2. The modified polynucleotide of claim 1 , wherein L is a group selected from sulfonyl, carbonyl esters, para nitrophenyl esters, nitrophenyl esters, trifluoroacetyl esters, nosylate, brosylate, tosylate, perchlorate, triflate, and mesylate.
3. The modified polynucleotide of claim 1 wherein Z is a quencher, and said polynucleotide further comprises at least one fluorophore quenched by Z.
4. A composition comprising a pair of polynucleotides, wherein said first polynucleotide is a modified polynucleotide according to claim 1 , and said second polynucleotide comprises a 3′ nucleophilic group.
5. A composition according to claim 4 , wherein said first and said second polynucleotides hybridize to neighboring sites on a target sequence.
6. The composition of claim 4 , wherein the nucleophilic group is a phosphorothioate or a phosphoroselenoate.
7. The composition of claim 4 , wherein said second polynucleotide comprises at least one fluorophore.
8. A kit for the detection of a nucleic acid sequence of interest, the kit comprising a modified polynucleotide according to claim 1 , and instructions for use.
9. A modified polynucleotide having the structure:
wherein:
Z is
T is (CH 2 ) n where n is from 2 to 20;
R is OCH 3 ;
and A is any nucleotide or part of a polynucleotide.
10. A composition comprising a pair of polynucleotides, wherein said first polynucleotide is a modified polynucleotide having the structure:
wherein T is a tether selected from the group consisting of:
where n is from 2 to 20; and n 1 and n 2 are independently selected to be from 1 to 20; n 1 +n 2 are usually not more than about 20; and y is from 1 to 7;
and wherein T is optionally substituted with an alkyl, aryl, alkenyl, aralkyl, aralkenyl, cycloalkyl, cycloalkylalkyl or cycloalkylalkenyl group;
R 3 is selected from an alkyl, usually branched or linear lower alkyl; hydroxy, alkoxy, aryloxy, haloalkoxy, cyano, nitro, mercapto, alkylthio, —S(O) p R 6 (where p is 0 to 2), —S(O) p N(R 6 ) 2 (where p is 0 to 2); —OR 6 , —C(O)OR 6 , —C(O)N(R 6 ) 2 , —N(R 6 ) 2 , —N(R 6 )C(O)OR 7 , —N(R 8 )C(O)R 8 , and —R 8 —N═N—O—R 7 ; where each R 6 , R 7 or R 8 is independently selected from the group consisting of hydrogen, alkyl, alkenyl, haloalkyl, haloalkenyl, awl, aralkyl, aralkenyl, cycloalkyl, cycloalkylalkyl and cycloalkylalkenyl;
L is an activated leaving group selected from sulfonyl, carbonyl esters, para nitrophenyl esters, nitrophenyl esters, trifluoroacetyl esters, nosylate, brosylate, tosylate, perchlorate, triflate, and mesylate;
Z is a fluorophore or quencher;
A is a nucleotide of at least 6 bases in length and not more than about 100 bases in length; and
R is OR 1 or O − ; wherein R 1 is a linear or branched lower alkyl;
and said second polynucleotide comprises at least one fluorophore or quencher, and comprises a 3′ nucleophilic group;
wherein said first and said second polynucleotides hybridize to neighboring sites on a target sequence.
11. The composition of claim 4 , wherein the nucleophilic group is a phosphorothioate or a phosphoroselenoate.
12. A modified polynucleotide according to claim 1 , wherein Z is a fluorophore selected from fluorescein, 5-carboxyfluorescein (5-FAM), 6-carboxyfluorescein (6-FAM), 2′,4′,1,4,-tetrachlorofluorescein (TET), 2′,4′,5′,7′,1,4-hexachlorofluorescein (HEX), =2′,7′-dimethoxy-4′,5′-dichloro-6-carboxyfluorescein (JOE); Cy3, CY5, Cy5.5, a dansyl derivative; 6-carboxytetramethylrhodamine (TAMRA), a BODIPY fluorophore, tetrapropano-6-carboxyrhodamine (ROX), ALEXA dye, and Oregon Green.
13. A modified polynucleotide according to claim 1 , wherein Z is a quencher selected from DABSYL (dimethylamino-azobenzene-sulfonyl) group, DANSYL (5-dimethylaminonaphthalenesulfonyl); DIMAPDABSYL ((p-dimethylamino-phenylazo) azobenzenesulfonyl), other azobenzene-sulfonyl groups, benzenesulfonyl groups, or arenesulfonyl groups, any of which may comprise substituents such as amino, dialkylamino, nitro, fluoro, and cyano groups; anthraquinone, nitrothiazole, and nitroimidazole compounds; rhodamine dyes (e.g., tetramethyl-6-carboxyrhodamine (TAMRA); ROX; cyanine; coumarin; BODIPY dyes; fluorescein dyes; and ALEXA dyes.
14. A composition according to claim 10 , wherein Z is a fluorophore selected from fluorescein, 5-carboxyfluorescein (5-FAM), 6-carboxyfluorescein (6-FAM), 2′,4′,1,4,-tetrachlorofluorescein (TET), 2′,4′,5′,7′,1,4-hexachlorofluorescein (HEX), =2′,7′-dimethoxy-4′,5′-dichloro-6-carboxyfluorescein (JOE); Cy3, CY5, Cy5.5, a dansyl derivative; 6-carboxytetramethylrhodamine (TAMRA), a BODIPY fluorophore, tetrapropano-6-carboxyrhodamine (ROX), ALEXA dye, and Oregon Green.
15. A composition according to claim 10 , wherein Z is a quencher selected from DABSYL (dimethylamino-azobenzene-sulfonyl) group, DANSYL (5-dimethylaminonaphthalenesulfonyl); DIMAPDABSYL ((p-dimethylamino-phenylazo) azobenzenesulfonyl), other azobenzene-sulfonyl groups, benzenesulfonyl groups, or arenesulfonyl groups, any of which may comprise substituents such as amino, dialkylamino, nitro, fluoro, and cyano groups; anthraquinone, nitrothiazole, and nitroimidazole compounds; rhodamine dyes (e.g., tetramethyl-6-carboxyrhodamine (TAMRA); ROX; cyanine; coumarin BODIPY dyes; fluorescein dyes; and ALEXA dyes.